PharmEasy Unicorn
PharmEasy: Funding Rounds
Disclosed round amounts over time, USD millions.
PharmEasy: Investors
360 One Alkram Ventures Bennett Coleman Micro Labs Limited MVS Ventures Manipal Education and Medical Group (MEMG) / Ranjan Pai 360 One Portfolios CDPQ Private Equity Evolution Debt Capital Goldman Sachs Prosus Temasek WSSS Investments EvolutionX Debt Capital Kotak Investment Advisors B Capital Think Investments TPG TPG Growth CDPQ Eight Roads LGT Lightrock Prosus Ventures Eight Roads Ventures India Bessemer Venture Partners F-Prime Capital Fundamentum Advisors InnoVen Capital
Acquisitions
| Date | Acquirer | Acquired | Amount | Source |
|---|---|---|---|---|
| 14 Sep 2021 | PharmEasy | aknamed | $144 Mn enterprise valuation (₹1,060 Cr) for a 67.3% controlling stake | source |
| 25 Jun 2021 | PharmEasy | thyrocare-technologies | ₹4,546 Cr (~$613.5 Mn) for a 66.1% stake | source |
| 25 May 2021 | PharmEasy | medlife | $250 Mn (reported, all-stock deal) | source |
FAQs on PharmEasy
How much funding has PharmEasy raised?
PharmEasy has raised $1.35 Bn across 9 tracked funding round(s), most recently on 2025-09-16. Figures are compiled from cited public sources.
Who are the investors in PharmEasy?
Investors in PharmEasy include 360 One, Alkram Ventures, Bennett Coleman, Micro Labs Limited, MVS Ventures, Manipal Education and Medical Group (MEMG) / Ranjan Pai, 360 One Portfolios, CDPQ Private Equity.